Zevra Therapeutics, Inc. (ZVRA) Capital expenditures 2016–2025
Zevra Therapeutics, Inc. (ZVRA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$835,000FY2025 · since FY2016: $643,000 → $835,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $835,000 | — |
| FY2024 | $0 | -100.0% |
| FY2023 | $296,000 | +218.3% |
| FY2022 | $93,000 | -8.8% |
| FY2021 | $102,000 | +209.1% |
| FY2020 | $33,000 | +26.9% |
| FY2019 | $26,000 | +23.8% |
| FY2018 | $21,000 | -88.4% |
| FY2017 | $181,000 | -71.9% |
| FY2016 | $643,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice